ArticleFrontiers in pharmacology2020

Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway.

Fangyi Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.